Teleflex Incorporated Forecasted to Post FY2024 Earnings of $13.70 Per Share (NYSE:TFX)

Teleflex Incorporated (NYSE:TFXFree Report) – Research analysts at Zacks Research lifted their FY2024 EPS estimates for shares of Teleflex in a research note issued on Thursday, May 9th. Zacks Research analyst R. Department now expects that the medical technology company will post earnings of $13.70 per share for the year, up from their prior estimate of $13.64. The consensus estimate for Teleflex’s current full-year earnings is $13.75 per share. Zacks Research also issued estimates for Teleflex’s Q2 2025 earnings at $3.74 EPS and Q4 2025 earnings at $4.07 EPS.

TFX has been the topic of several other reports. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Friday, May 3rd. Truist Financial cut their target price on Teleflex from $240.00 to $219.00 and set a “hold” rating on the stock in a research report on Friday, May 3rd. StockNews.com downgraded Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 23rd. JMP Securities reiterated a “market outperform” rating and set a $285.00 price objective on shares of Teleflex in a research report on Friday, February 23rd. Finally, Royal Bank of Canada lowered their target price on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a report on Friday, February 23rd. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Teleflex presently has an average rating of “Moderate Buy” and an average target price of $261.75.

Check Out Our Latest Stock Analysis on Teleflex

Teleflex Trading Up 2.7 %

Shares of TFX opened at $212.62 on Monday. Teleflex has a fifty-two week low of $177.63 and a fifty-two week high of $262.97. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 2.51. The company’s fifty day moving average is $214.66 and its 200 day moving average is $227.29. The stock has a market capitalization of $10.01 billion, a PE ratio of 34.13, a P/E/G ratio of 1.97 and a beta of 1.13.

Teleflex (NYSE:TFXGet Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The medical technology company reported $3.21 EPS for the quarter, beating the consensus estimate of $3.07 by $0.14. Teleflex had a return on equity of 14.78% and a net margin of 9.82%. The business had revenue of $737.80 million for the quarter, compared to the consensus estimate of $726.85 million. During the same period in the previous year, the business earned $3.09 earnings per share. The business’s revenue was up 3.8% on a year-over-year basis.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Wednesday, May 15th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.64%. The ex-dividend date is Tuesday, May 14th. Teleflex’s dividend payout ratio is presently 21.83%.

Insider Activity at Teleflex

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the firm’s stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total transaction of $1,665,225.00. Following the transaction, the vice president now directly owns 10,050 shares in the company, valued at approximately $2,261,250. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.43% of the stock is owned by company insiders.

Institutional Investors Weigh In On Teleflex

Several large investors have recently modified their holdings of the business. Rafferty Asset Management LLC increased its holdings in Teleflex by 6.8% during the third quarter. Rafferty Asset Management LLC now owns 4,910 shares of the medical technology company’s stock valued at $964,000 after buying an additional 314 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in shares of Teleflex by 243.6% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 22,722 shares of the medical technology company’s stock valued at $5,666,000 after acquiring an additional 16,110 shares during the period. Tokio Marine Asset Management Co. Ltd. raised its position in shares of Teleflex by 22.3% in the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,366 shares of the medical technology company’s stock worth $341,000 after acquiring an additional 249 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Teleflex by 3.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 405,203 shares of the medical technology company’s stock worth $101,033,000 after purchasing an additional 12,150 shares during the last quarter. Finally, Royal London Asset Management Ltd. boosted its position in Teleflex by 4.3% during the third quarter. Royal London Asset Management Ltd. now owns 17,753 shares of the medical technology company’s stock valued at $3,487,000 after purchasing an additional 737 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

About Teleflex

(Get Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

See Also

Earnings History and Estimates for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.